What EFOR does

Efor Group is a France-based professional services firm specializing in quality and compliance for the life sciences industry, headquartered in Lyon and operating across 18 countries with approximately 3,200 employees and reported revenues of €375+ million. The company delivers an integrated suite of services built around Commissioning, Qualification & Validation (CQV), Computer System Validation (CSV), Digital Validation, Quality Management, Engineering, Regulatory Affairs, Clinical Research Organization (CRO) services, Audit, and Training. Its stated client base covers approximately 90% of top pharmaceutical companies, with particular emphasis on breakthrough therapy subsegments such as GLP-1, oncology, and cell and gene therapy manufacturing.

The firm operates on a project-based, custom enterprise engagement model with multi-year contracts and quote-based pricing tailored to client scope. Its go-to-market is enterprise field sales targeting large multinational pharmaceutical and biotechnology manufacturers, supported by content marketing, technical publications, and industry events. Service delivery increasingly incorporates AI-enabled tools and a Digital Validation Platform intended to integrate with traditional CQV/CSV services, accelerate time-to-market, and strengthen compliance.

Efor's growth has been driven by a combination of organic expansion and targeted acquisitions. In March 2026, the company acquired DynamixE (U.S.) to gain immediate access to the world's largest life sciences consulting market — boosting U.S. revenue to nearly $60 million — and No Deviation (Singapore) to add over 300 professionals and an established operational base in Shanghai. The company competes in a global life sciences consulting market sized at $34 billion, growing at roughly 9% annually, with the U.S. representing over 50% of that opportunity.

Name

EFOR

Legal name

Efor Group

Website

https://efor-group.fr

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Efor Group is a France-based professional services firm delivering quality and compliance consulting — including CQV, CSV, digital validation, and quality management — to life sciences companies across 18 countries, serving roughly 90% of top pharmaceutical manufacturers worldwide.

Ownership category

akta.pro rank

Product category

Life Sciences Quality & Compliance Consulting

NAICS

Other Scientific and Technical Consulting Services (54169), Other Computer Related Services (541519)

SIC

Services-Engineering, Accounting, Research, Management (8700), Services-Engineering Services (8711)

akta.pro primary industry

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Quality compliance consulting
• Commissioning qualification validation
• Life sciences consulting
• Computer system validation
• Regulatory affairs services

Headquarters

HQ city

Caluire

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Quality and Compliance Professional Services: Professional services revenue from CQV (Commissioning, Qualification & Validation), CSV (Computer System Validation), Quality Management, and related consulting services delivered to life sciences companies globally
2. North American Operations: Revenue generated from U.S. operations including biopharmaceutical manufacturing services, process engineering, and digitalization. North American operations generate nearly $60 million in revenue out of approximately $400 million worldwide

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

EFOR is a global quality and compliance consulting firm serving the life sciences industry. The company delivers CQV (Commissioning, Qualification & Validation), CSV (Computer System Validation), Digital Validation, Quality Management, Engineering, Regulatory Affairs, Audit, Training, and CRO services to pharmaceutical and biotechnology companies across 18 countries. Leveraging AI-enabled tools and digital solutions, EFOR helps clients embed regulatory compliance into their manufacturing operations and accelerate time-to-market for breakthrough therapies.

Product overview

Efor is a global leader in quality and compliance for the Life Sciences industry, offering an integrated suite of professional services organized around CQV (Commissioning, Qualification & Validation), CSV (Computer System Validation), Digital Validation, Quality Management, Engineering, Regulatory Affairs, CRO, Audit, and Training. The company combines worldwide reach with deep local capability, implementing CQV & CSV delivery, quality management and process industrialization to ongoing manufacturing excellence across global sites. Efor leverages AI-enabled tools and advanced digital solutions, bringing together rigorous technical know-how, scalable delivery models, and AI-enabled tools to help clients navigate the most complex regulatory environments. Operating across 18 countries with 375+ million euros in revenues and 3,200 employees, Efor supports companies at every stage with strong project management and project controls expertise, serving 90% of top pharmaceutical companies worldwide.

Differentiator

Problem solved

Functional benefit

Products and services

• CQV (Commissioning, Qualification & Validation) Comprehensive CQV services ensuring equipment, facilities, and systems meet regulatory requirements and operational specifications for life sciences manufacturing.
• CSV (Computer System Validation) Validation services for computerized systems ensuring compliance with regulatory standards (e.g., GAMP, 21 CFR Part 11) in regulated life sciences environments.
• Digital Validation AI-enabled digital validation solutions leveraging advanced technologies to modernize and accelerate validation processes for life sciences compliance.
• Quality Management Quality management services helping life sciences companies maintain cGMP compliance and operational excellence across global manufacturing sites.
• Engineering Engineering services supporting life sciences manufacturing operations and infrastructure, including strong project management and project controls expertise.
• Regulatory Affairs Regulatory affairs consulting to help life sciences clients navigate complex multi-jurisdiction regulatory environments and ensure market compliance for drugs and health products.
• CRO (Clinical Research Organization) Clinical research services supporting drug development and clinical trials across the life sciences ecosystem.
• Audit Audit services for compliance verification and quality assurance across life sciences operations, including GMP audits and supplier qualification.
• Training Training services for life sciences professionals covering compliance, quality, regulatory, and technical topics to upskill internal teams.
• AI & Advanced Technologies AI-enabled tools and digital solutions that accelerate time-to-market, strengthen compliance, and boost operational efficiency for life sciences companies.

Quantifiable outcome

• 90% of top pharmaceutical companies served as clients
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• No DeviationcoreStrategic or Co-development Partner · 5 March 2026Acquisition of Singapore-based No Deviation, a Life Sciences services company specializing in CQV, CSV, Quality Compliance, and Digital Enablement. Founded in 2007, No Deviation operates across Singapore, China, and Ireland with a team of approximately 30-100 professionals. The acquisition reinforces Efor's presence in Asia with over 300 professionals regionally, providing an established operational base in Shanghai and direct access to key industrial stakeholders in China.
• DynamixE, Inc.coreStrategic or Co-development Partner · 2 March 2026Acquisition of U.S.-based DynamixE, Inc., a specialized firm in biopharmaceutical manufacturing services including CQV, process engineering, and digitalization. Founded in New York in 2017, DynamixE operates across major U.S. life sciences hubs including North Carolina, Massachusetts, California, Texas, New Jersey, and Pennsylvania, specializing in biologics and cell and gene therapy biomanufacturing environments. The acquisition immediately boosts Efor's U.S. revenue to nearly $60 million and positions the company in the world's largest life sciences market.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Azzur Group: Azzur Group is a U.S.-based life sciences consulting and CQV/validation services firm serving pharma and biotech manufacturers. It is one of the most direct U.S. competitors in CQV, CSV and quality management that EFOR now faces through its DynamixE acquisition.
• PharmaLex: PharmaLex (now part of Cencora/PharmaLex) is a specialist regulatory, quality and compliance consulting firm serving life sciences. It is one of the closest direct comparables to EFOR's regulatory affairs and quality management practices in terms of focus and customer base.
• KCR: KCR is a clinical research and consulting services provider for life sciences, with capabilities across CRO, regulatory and quality. It is a mid-sized European-rooted peer comparable to EFOR in scale and service breadth.
• Tunnell Consulting: Tunnell Consulting is a U.S. life sciences management consulting firm focused on pharma manufacturing, quality and operational excellence. It targets the same top-pharma enterprise buyer set as EFOR with a similar services-led model.
• Commissioning Agents Inc. (CAI): CAI is a global CQV, engineering and compliance services firm dedicated to regulated life sciences manufacturing. It competes head-to-head with EFOR on commissioning, qualification and validation projects for pharma and biotech manufacturers.

Broad incumbents

• ICON plc: ICON is a top-3 global CRO and life sciences services firm with growing consulting, labs and decentralized clinical capabilities. It overlaps with EFOR's CRO and regulatory/quality practices and competes for the same top-pharma enterprise contracts.
• IQVIA: IQVIA is the largest global life sciences services company, offering clinical, consulting, technology and compliance/quality services to pharma and biotech. It is the broadest incumbent competing across many of EFOR's service lines at significantly larger scale.
• Parexel: Parexel is a global CRO with biopharmaceutical development, regulatory and consulting services. It competes with EFOR for CRO, regulatory affairs and quality compliance engagements with top pharma clients.
• Labcorp Drug Development (formerly Covance): Labcorp's Drug Development segment offers CRO and central lab services to pharma and biotech, competing with EFOR's CRO and broader life sciences services portfolio at much larger scale.
• Charles River Laboratories: Charles River provides life sciences research, manufacturing support and CDMO services to pharma and biotech. Its Manufacturing Solutions segment directly overlaps EFOR's CQV, validation and biomanufacturing quality offerings.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks1 record

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC1-EIfM_gKiPiYtg5vDfZow
• LinkedInlinkedin.com/company/efor-groupe
• Instagraminstagram.com/eforgroup_

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EFOR